PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) presents at metastatic stage in over 50% of patients. With a survival rate of just 2.7% for patients presenting with distant disease, it is imperative to uncover novel mechanisms capable of suppressing metastasis in PDAC. Previously, we reported that the loss...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeleniak, Ann E., Huang, Wei, Fishel, Melissa L., Hill, Reginald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714254/
https://www.ncbi.nlm.nih.gov/pubmed/29175021
http://dx.doi.org/10.1016/j.neo.2017.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714254/
https://www.ncbi.nlm.nih.gov/pubmed/29175021
http://dx.doi.org/10.1016/j.neo.2017.10.004

Ejemplares similares